Picture of Shanghai Bio-heart Biological Technology logo

2185 — Shanghai Bio-heart Biological Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareMicro CapSucker Stock

Brief: Shanghai Bio-Heart Biological Technology Contracts With CERC For European Clinical Trial For Iberis 2nd

Dec 29 (Reuters) - Shanghai Bio-heart Biological Technology
Co Ltd  2185.HK :
    * SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY- CONTRACTED WITH
EUROPEAN CARDIOVASCULAR RESEARCH CENTER TO CONDUCT EUROPEAN
CLINICAL TRIAL FOR IBERIS 2ND

Source text for Eikon:  ID:nHKS9lZv9Z 
Further company coverage:  2185.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shanghai Bio-heart Biological Technology

See all news